Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions

• Angela I. Schriek,
• Marlies M. van Haaren,
• Meliawati Poniman,
• Gillian Dekkers,
• Arthur E. H. Bentlage,
• Marloes Grobben,
• Gestur Vidarsson,
• Rogier W. Sanders,
• Rogier W. Sanders,
• Theo Verrips,
• Theo Verrips,
• Teunis B. H. Geijtenbeek,
• Raimond Heukers,
• Neeltje A. Kootstra,
• Steven W. de Taeye,
• Marit J. van Gils

Affiliations

Angela I. Schriek

Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands

Marlies M. van Haaren

Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands

Meliawati Poniman

Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands

Gillian Dekkers

QVQ Holding BV, Utrecht, Netherlands

Arthur E. H. Bentlage

Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Marloes Grobben

Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands

Gestur Vidarsson

Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Rogier W. Sanders

Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands

Rogier W. Sanders

Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, United States

Theo Verrips

Department of Biology, Faculty of Sciences, Utrecht University, Utrecht, Netherlands

Theo Verrips

VerLin BV, Utrecht, Netherlands

Teunis B. H. Geijtenbeek

Department of Experimental Immunology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands

Raimond Heukers

QVQ Holding BV, Utrecht, Netherlands

Neeltje A. Kootstra

Department of Experimental Immunology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands

Steven W. de Taeye

Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands

Marit J. van Gils

Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands